BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van der Made CI, Potjewijd J, Hoogstins A, Willems HPJ, Kwakernaak AJ, de Sevaux RGL, van Daele PLA, Simons A, Heijstek M, Beck DB, Netea MG, van Paassen P, Elizabeth Hak A, van der Veken LT, van Gijn ME, Hoischen A, van de Veerdonk FL, Leavis HL, Rutgers A. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS. J Allergy Clin Immunol 2021:S0091-6749(21)00819-8. [PMID: 34048852 DOI: 10.1016/j.jaci.2021.05.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Delplanque M, Aouba A, Hirsch P, Fenaux P, Graveleau J, Malard F, Roos-Weil D, Belfeki N, Drevon L, Oganesyan A, Groh M, Mahévas M, Razanamahery J, Maigne G, Décamp M, Miranda S, Quemeneur T, Rossignol J, Sailler L, Sébert M, Terriou L, Sevoyan A, Hakobyan Y, Georgin-Lavialle S, Mekinian A. USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still's Disease in Elderly Patients. J Clin Med 2021;10:5586. [PMID: 34884286 DOI: 10.3390/jcm10235586] [Reference Citation Analysis]
2 Nicholson LT, Madigan LM. Working towards a better understanding of VEXAS syndrome. Br J Dermatol 2022. [PMID: 35230698 DOI: 10.1111/bjd.20949] [Reference Citation Analysis]
3 Martín-Nares E, Vargas-Serafín C, Delgado-de la Mora J, Montante-Montes de Oca D, Grayson PC, Larios E, Crispín JC. Orbital and periorbital inflammation in VEXAS syndrome. Scand J Rheumatol 2022;:1-4. [PMID: 35302406 DOI: 10.1080/03009742.2022.2045791] [Reference Citation Analysis]
4 Comont T, Heiblig M, Rivière E, Terriou L, Rossignol J, Bouscary D, Rieu V, Le Guenno G, Mathian A, Aouba A, Vinit J, Dion J, Kosmider O, Terrier B, Georgin-Lavialle S, Fenaux P, Mekinian A; French VEXAS study group, Groupe Francophone des Myélodysplasies (GFM) and MedecineINterne, HEmato et ONco (MINHEMON) group. Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry. Br J Haematol 2021. [PMID: 34651299 DOI: 10.1111/bjh.17893] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Oo TM, Koay JTJ, Lee SF, Lee SMS, Lim XR, Fan BE. Thrombosis in VEXAS syndrome. J Thromb Thrombolysis 2021. [PMID: 34817788 DOI: 10.1007/s11239-021-02608-y] [Reference Citation Analysis]
6 Koster MJ, Warrington KJ. VEXAS within the spectrum of rheumatologic disease. Semin Hematol 2021;58:218-25. [PMID: 34802543 DOI: 10.1053/j.seminhematol.2021.10.002] [Reference Citation Analysis]
7 Kirino Y, Takase-Minegishi K, Tsuchida N, Hirahara L, Kunishita Y, Yoshimi R, Nakajima H. Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan. Ann Rheum Dis 2021:annrheumdis-2021-220876. [PMID: 34260381 DOI: 10.1136/annrheumdis-2021-220876] [Reference Citation Analysis]
8 Patel BA, Young NS. Towards treatments for VEXAS. Br J Haematol 2021. [PMID: 34729765 DOI: 10.1111/bjh.17930] [Reference Citation Analysis]
9 Islam S, Cullen T, Sumpton D, Damodaran A, Heath D, Bosco A, Doo NW, Kidson-Gerber G, Cheong A, Lawford R, Walsh R, Sammel A. VEXAS syndrome: lessons learnt from an early Australian case series. Intern Med J 2022;52:658-62. [PMID: 35419965 DOI: 10.1111/imj.15742] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Groarke EM, Dulau-Florea AE, Kanthi Y. Thrombotic manifestations of VEXAS syndrome. Semin Hematol 2021;58:230-8. [PMID: 34802545 DOI: 10.1053/j.seminhematol.2021.10.006] [Reference Citation Analysis]
11 Kunishita Y, Kirino Y, Tsuchida N, Maeda A, Sato Y, Takase-minegishi K, Yoshimi R, Nakajima H. Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan. Front Immunol 2022;13:901063. [DOI: 10.3389/fimmu.2022.901063] [Reference Citation Analysis]
12 Koster MJ, Kourelis T, Reichard KK, Kermani TA, Beck DB, Cardona DO, Samec MJ, Mangaonkar AA, Begna KH, Hook CC, Oliveira JL, Nasr SH, Tiong BK, Patnaik MM, Burke MM, Michet CJ Jr, Warrington KJ. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series. Mayo Clin Proc 2021;96:2653-9. [PMID: 34489099 DOI: 10.1016/j.mayocp.2021.06.006] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]